- Home
- WOLF vs SIGA Comparison
WOLF vs SIGA Comparison
Compare WOLF & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOLF | SIGA |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 486.2M |
| IPO Year | 1993 | 1997 |
Fundamental Metrics
Financial Performance| Metric | WOLF | SIGA |
|---|---|---|
| Price | $18.88 | $6.78 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.75 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 326.2K |
| Earning Date | 02-04-2026 | 03-10-2026 |
| Dividend Yield | N/A | ★ 8.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $747,700,000.00 | $172,249,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.39 | $132.36 |
| P/E Ratio | ★ N/A | $6.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.05 | $4.95 |
| 52 Week High | $36.60 | $9.62 |
Technical Indicators
Market Signals| Indicator | WOLF | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 54.33 |
| Support Level | $15.85 | $6.51 |
| Resistance Level | $18.25 | $7.02 |
| Average True Range (ATR) | 1.90 | 0.26 |
| MACD | 0.25 | -0.01 |
| Stochastic Oscillator | 84.18 | 50.39 |
Price Performance
Historical ComparisonAbout WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.